Pan Yan-Hong, Wang Min, Huang Yan-Mei, Wang Ying-Hui, Chen Yin-Ling, Geng Li-Jun, Zhang Xiao-Xi, Zhao Hai-Lu
Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541004, China; Institute of Basic Medical Sciences, Guilin Medical University, Guilin 541004, China; Department of Immunology, Faculty of Basic Medicine, Guilin Medical University, Guilin 541004, China.
Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin 541004, China; Institute of Basic Medical Sciences, Guilin Medical University, Guilin 541004, China.
Dis Markers. 2016;2016:7420540. doi: 10.1155/2016/7420540. Epub 2016 Dec 26.
Association between ACE gene I/D polymorphism and the risk of overweight/obesity remains controversial. We investigated the possible relationship between ACE gene I/D polymorphism and obesity in Chinese type 2 diabetes mellitus (T2DM) patients. In this study, obesity was defined as a body mass index (BMI) value ≥ 25 kg/m and subjects were classified into 4 groups (lean, normal, overweight, and obese). PCR (polymerase chain reaction) was used to detect the ACE gene I/D polymorphism in T2DM patients. Metabolic measurements including blood glucose, lipid profile, and blood pressure were obtained. Frequencies of the ACE genotypes (DD, ID, and II) were not significant among the 4 groups of BMI-defined patients ( = 0.679) while ACE II carriers showed higher systolic blood pressure (SBP) and pulse pressure (PP) (all < 0.050). Hyperglycemia, hypertension, and dyslipidemia in these T2DM patients were found to be significantly associated with BMI. In conclusion, the relationship of ACE gene I/D polymorphism with obesity is insignificant in Chinese patients with T2DM. SBP and PP might be higher in the ACE II carriers than in the DD and ID carriers.
血管紧张素转换酶(ACE)基因I/D多态性与超重/肥胖风险之间的关联仍存在争议。我们调查了中国2型糖尿病(T2DM)患者中ACE基因I/D多态性与肥胖之间的可能关系。在本研究中,肥胖定义为体重指数(BMI)值≥25kg/m²,受试者被分为4组(消瘦、正常、超重和肥胖)。采用聚合酶链反应(PCR)检测T2DM患者的ACE基因I/D多态性。获取了包括血糖、血脂谱和血压在内的代谢测量值。在BMI定义的4组患者中,ACE基因型(DD、ID和II)的频率无显著差异(P = 0.679),而ACE II携带者的收缩压(SBP)和脉压(PP)较高(均P < 0.050)。这些T2DM患者的高血糖、高血压和血脂异常与BMI显著相关。总之,在中国T2DM患者中,ACE基因I/D多态性与肥胖的关系不显著。ACE II携带者的SBP和PP可能高于DD和ID携带者。